Welcome to our dedicated page for Esquire Finl Hldgs SEC filings (Ticker: ESQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Esquire Financial Holdings, Inc. (NASDAQ: ESQ) SEC filings page provides access to the company’s official regulatory disclosures as a Maryland-incorporated financial holding company. Esquire’s common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades on The Nasdaq Stock Market LLC under the symbol ESQ. Through these filings, investors can review how Esquire reports its financial condition, operating results, capital position, and material corporate events.
Esquire uses current reports on Form 8-K to announce key developments such as quarterly earnings results, regular quarterly dividends for common stockholders, and significant corporate actions like its new headquarters lease in Jericho, New York. These 8-K filings often reference attached press releases and investor presentations that provide additional detail on net income, returns on average assets and equity, net interest margin, loan and deposit growth, credit quality, and noninterest income from its payment processing platform.
In addition to 8-Ks, investors can consult Esquire’s annual reports on Form 10-K and quarterly reports on Form 10-Q (when available in the broader SEC record) for comprehensive discussions of its business model as a full-service commercial bank focused on the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. These periodic reports typically include information on segment performance, securities and loan portfolios, funding through core deposits, and risk management practices.
Stock Titan’s filings page is designed to surface ESQ filings as they are posted to the SEC’s EDGAR system and to pair them with AI-powered summaries. These summaries can help explain complex sections of lengthy documents, highlight key changes from prior periods, and point out items such as dividend declarations, capital ratios, and developments in Esquire’s national litigation platform and payment processing operations. Users can also track insider and executive share transactions through Form 4 filings when they are available, gaining additional context on equity ownership and incentives.
Esquire Financial Holdings, Inc. disclosed that one of its directors acquired 753 shares of restricted common stock on December 10, 2025 at a stated price of $0 as a restricted stock award. After this transaction, the director beneficially owns 2,620 shares of common stock in direct ownership.
The 753 restricted shares are scheduled to vest 100% on December 10, 2026. The reported holdings also include additional restricted stock that will vest in three equal annual installments beginning on December 3, 2027.
Esquire Financial Holdings, Inc. reported an insider equity award involving one of its directors. On December 10, 2025, the director acquired 753 shares of common stock in a transaction reported with code "A" at a stated price of $0, indicating a grant rather than an open-market purchase.
These shares are described as restricted stock that will vest 100% on December 10, 2026. Following this transaction, the director beneficially owned 753 shares, held as direct ownership. The filing is made by a single reporting person in their capacity as a director.
Esquire Financial Holdings, Inc. reported that one of its directors acquired 753 shares of common stock as a restricted stock award on December 10, 2025, at a price of $0. These restricted shares vest 100% on December 10, 2026. Following this grant, the director beneficially owns 87,352 shares directly, plus 48,000 shares held indirectly as trustee for trusts and 12,000 shares held indirectly as custodian for children. The director also holds fully vested stock options covering 584 shares of common stock with an exercise price of $31.04, exercisable since December 9, 2022 and expiring on December 9, 2031.
Esquire Financial Holdings, Inc.'s senior vice president and chief financial officer reported a transaction in the company's common stock dated December 9, 2025. The filing shows a disposition of 300 shares of common stock, coded "F", at a price of $104.04 per share.
After this transaction, the officer beneficially owns 18,612 shares of common stock directly, which include restricted stock awards vesting in three equal annual installments commencing on December 19, 2023, December 16, 2024, December 9, 2025, December 19, 2026, December 15, 2027, and January 30, 2028, and 1,500 shares indirectly through an IRA. The officer also holds stock options covering 1,500 shares at an exercise price of $24.9 and four grants of 2,500 shares each at exercise prices of $20.85, $31.04, $42.3, and $48.32, with expiration dates on December 10, 2028, December 16, 2030, December 9, 2031, December 19, 2032, and December 15, 2033.
Esquire Financial Holdings, Inc. reported an insider transaction by its executive vice president and head of corporate development. On December 9, 2025, the officer disposed of 1,997 shares of common stock at $104.04 per share under transaction code "F," leaving 102,647 shares directly beneficially owned.
The officer also beneficially owns 1,947 shares of common stock indirectly through an IRA. The directly held common stock includes multiple restricted stock awards that vest in three equal annual installments beginning on various dates from December 19, 2023 through January 30, 2028, and the officer holds fully vested stock options for 7,500 shares and 11,125 shares at a $12.50 exercise price, expiring in 2026.
Esquire Financial Holdings, Inc. reported an insider transaction by a senior executive who serves as Vice Chairman, President & CEO and a director. On December 9, 2025, the executive disposed of 5,181 shares of common stock at $104.04 in a transaction coded "F," leaving 276,237 shares beneficially owned directly.
These holdings include multiple grants of restricted stock that vest in three equal annual installments beginning on dates from December 19, 2023 through January 30, 2028. The executive also holds fully vested stock options covering 29,250 shares with a $12.50 exercise price, expiring on September 1, 2026.
Esquire Financial Holdings (ESQ) filed its Q3 2025 10‑Q, showing solid growth and stable credit. Net income was $14.1 million versus $11.4 million a year ago, and diluted EPS was $1.62 versus $1.34. Net interest income rose to $31.3 million, helped by loan growth, while the provision for credit losses was $1.8 million.
Total assets reached $2.18 billion, up from $1.89 billion at year‑end 2024. Loans held for investment were $1.55 billion and deposits were $1.88 billion, led by savings, NOW and money market balances of $1.27 billion. Noninterest income was $6.2 million, with payment processing fees of $5.1 million.
Noninterest expense was $18.4 million, reflecting higher compensation and data processing costs. Credit quality metrics remained manageable: the allowance for credit losses was $21.1 million, and past due/nonaccrual balances were low. One multifamily loan was restructured earlier in 2025; the current carrying amount was $7.9 million at quarter‑end.
Esquire Financial Holdings, Inc. declared a regular quarterly dividend of $0.175 per share. The dividend is payable on December 1, 2025 to stockholders of record as of November 14, 2025. This reflects the company’s ongoing capital return through routine cash dividends.
Esquire Financial Holdings (ESQ)
The press release is furnished as Exhibit 99.1 and the presentation as Exhibit 99.2. The materials in Items 2.02 and 7.01, including Exhibits 99.1 and 99.2, are being furnished, not filed, and are not subject to Section 18 of the Exchange Act, nor incorporated by reference except as expressly stated.
Esquire Financial Holdings director Joseph Melohn reported multiple sales of the company's common stock on 08/26/2025. The Form 4 shows a series of dispositions of common stock recorded at prices ranging from $99.00 to $100.50 across several line items. The filings indicate shares were held indirectly ("By LLC") and additional indirect holdings are noted as "By Mother." The Form 4 also lists restricted stock grants that vest in three equal annual installments beginning in December 2026 and December 2027 for specific tranches. The submission was signed by an authorized representative on 08/27/2025.
FAQ
What is the current stock price of Esquire Finl Hldgs (ESQ)?
What is the market cap of Esquire Finl Hldgs (ESQ)?
